4-[(2~{S},3~{R},4~{S},5~{S},6~{R})-6-(hydroxymethyl)-3,4,5-tris(oxidanyl)oxan-2-yl]sulfanylbenzenesulfonamide

InChIKey	`NIQIGNHEHFIPGG-ZIQFBCGOSA-N`
Compound Name	4-[(2~{S},3~{R},4~{S},5~{S},6~{R})-6-(hydroxymethyl)-3,4,5-tris(oxidanyl)oxan-2-yl]sulfanylbenzenesulfonamide
Canonical SMILES	`NS(=O)(=O)c1ccc(S[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc1`
Clinical Status	Data-mined Candidate
Targets (Human+Pathogen)	7
Pfam Stratification	Homologous
Avg pChEMBL	6.91
Source	ChEMBL

2D Structure

Activity Profile

Target	Gene	Organism	Category	Pfam	pChEMBL	Type	Source
P00918	CA2	Homo sapiens	Human	PF00194	8.1	Ki	ChEMBL
P43166	CA7	Homo sapiens	Human	PF00194	7.3	Ki	ChEMBL
P35218	CA5A	Homo sapiens	Human	PF00194	7.1	Ki	ChEMBL
O43570	CA12	Homo sapiens	Human	PF00194	7.0	Ki	ChEMBL
Q9Y2D0	CA5B	Homo sapiens	Human	PF00194	6.3	Ki	ChEMBL
P22748	CA4	Homo sapiens	Human	PF00194	6.2	Ki	ChEMBL
P00915	CA1	Homo sapiens	Human	PF00194	6.2	Ki	ChEMBL